Protein Summary
Functions as an anchor sequestering components of the cAMP-dependent pathway to Golgi and/or centrosomes (By similarity). Isoform 13: Participates in microtubule dynamics, promoting microtubule assembly. Depending upon the cell context, may act at the level of the Golgi apparatus or that of the centrosome (PubMed:25217626, PubMed:27666745, PubMed:28814570, PubMed:29162697). In complex with AKAP9, recruits CAMSAP2 to the Golgi apparatus and tethers non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745, PubMed:28814570). In complex with AKAP9, EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation and extension from the centrosome to the cell periphery, a crucial process for directed cell migration, mitotic spindle orientation and cell-cycle progression (PubMed:29162697).
- ENST00000313431
- ENSP00000316434
- ENSG00000178104
- ENST00000369347
- ENSP00000358353
- ENST00000369349
- ENSP00000358355
- ENST00000369351
- ENSP00000358357
- ENST00000369354
- ENSP00000358360
- ENST00000369356
- ENSP00000358363
- ENST00000529945
- ENSP00000433392
- ENST00000530472
- ENSP00000482121
- ENST00000618462
- ENSP00000479409
- CMYA2
- KIAA0454
- KIAA0477
- MMGL
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
transcription factor perturbation | 1 | ||
PubMedID | 0.97 | ||
disease perturbation | 0.95 | ||
kinase perturbation | 0.88 | ||
transcription factor | 0.87 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 39.72 (req: < 5)
Gene RIFs: 10 (req: <= 3)
Antibodies: 109 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 39.72 (req: >= 5)
Gene RIFs: 10 (req: > 3)
Antibodies: 109 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 6
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0